Amir F Heshmatpour has bought NTHI on 12 days since May 2025

Amir F. Heshmatpour is the CEO, Executive Chairman, and President of NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company developing innovative therapeutics for central nervous system cancers using its NEO™ drug platform.( Appointed President in April 2025 while retaining his Chairman role, he oversees day-to-day operations to advance clinical programs like NEO212 and NEO100, allowing CEO Dr. Thomas Chen to focus on trials.(

Heshmatpour brings over 25 years of executive experience in business development, operations, finance, and M&A.( He founded AFH Holdings & Advisory, leading IPOs over $1.5 billion and private deals exceeding $5 billion; previously founded Metrophone Telecommunications in 1994, growing it to $100 million in revenue via 17 acquisitions.( A board member of UCLA Anderson School of Management (12+ years) and Make-A-Wish Foundation, he owns ~7.5 million NTHI shares worth ~$43 million as of April 2026 and sold 38,464 shares in March 2025.( Motivated personally by family loss to brain cancer, he expanded NeOnc into Israel and UAE for trials and investments.(

Written by Perplexity from public sources.